Tag: HARPOON THERAPEUTICS

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to HARPOON THERAPEUTICS

Harpoon Therapeutics Appoints Experienced Biotech Leader Alan Colowick, MD, to Board of ...

Added to Collection on: 2021-03-24 21:11:15

Tags for this article:

Life Sciences
Bristol-Myers Squibb
Celgene
Summit, New Jersey
Sofinnova
Biotechnology
Industry economics)
Alan Colowick
Harpoon Therapeutics Inc.
HARPOON THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Harpoon Therapeutics to Participate in Truist Securities Life Sciences Summit

Added to Collection on: 2024-04-10 09:54:57

Tags for this article:

Branches of biology
Biology
Mesothelin
Proteins
Glutamate carboxypeptidase II
Cancer
HARPOON THERAPEUTICS
Harpoon Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Harpoon Therapeutics Presents Interim Clinical Data from its Ongoing Phase 1/2 Study and ...

Added to Collection on: 2021-12-12 02:29:52

Tags for this article:

Protein domains
B-cell maturation antigen
Biotechnology
Branches of biology
Clinical medicine
Biology
Cancer immunotherapy
T cells
Serum B-cell maturation antigen
Harpoon Therapeutics Inc.
HARPOON THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides

Added to Collection on: 2022-03-11 03:37:13

Tags for this article:

Guided missiles
Weapons
Life Sciences
Harpoon
AbbVie
Harpoon Therapeutics Inc.
HARPOON THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Merck Buys Harpoon Therapeutics To Expand Its Oncology Portfolio - Investopedia

Added to Collection on: 2024-01-08 19:31:31

Tags for this article:

Bayer
Kenilworth, New Jersey
Merck & Co.
Schering-Plough
Pembrolizumab
Key Takeaways Merck & Co.
HARPOON THERAPEUTICS
Harpoon Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Merck expands cancer immunotherapy pipeline with $680m Harpoon acquisition - PMLiVE

Added to Collection on: 2024-01-11 18:17:38

Tags for this article:

Cancer immunotherapy
Bayer
Kenilworth, New Jersey
Merck & Co.
Schering-Plough
Orphan drugs
PD-1 and PD-L1 inhibitors
Roche
Atezolizumab
HARPOON THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details